Mouth Neoplasm
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization (NCT04065737) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2019-08-15 |
Track Mouth Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.